New Antipsychotic Strategies: Quetiapine and Risperidone vs. Fluphenazine in Treatment Resistant Schizophrenia
Clinical trial NCT00161018 · COMPLETED
Trial details
- NCT number
- NCT00161018
- Sponsor
- University of Maryland, Baltimore
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-11-01
- Primary completion
- 2004-11-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.